← All Sponsors
SPONSOR

Eileen Connolly

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Triple Negative Breast Cancer
NCT02977468 Phase 1
Recruiting

Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer

Triple Negative Breast Cancer
United States View Trial →